Henry Schein Inc (HSIC) Stock AnalysisHSICHenry Schein Inc

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.